Inhibitors of 2,3-oxidosqualene lanosterol-cyclase as potential antifungal agents.
F. Hoffmann-La Roche and Co. Ltd, Basel, Switzerland.
S
S
Jolidon
A M
AM
Polak
P
P
Guerry
P G
PG
Hartman
D000818:Animals; D000935:Antifungal Agents / Q000494:pharmacology*; D002176:Candida albicans / Q000187:drug effects / Q000378:metabolism; D005658:Fungi / Q000187:drug effects / Q000201:enzymology; D006801:Humans; D019751:Intramolecular Transferases; D007535:Isomerases / Q000037:antagonists & inhibitors*; D008099:Liver / Q000166:cytology / Q000378:metabolism
D000935:Antifungal Agents; D007535:Isomerases; D019751:Intramolecular Transferases; C021924:lanosterol synthase